
HarborSite
Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases
- Отрасль
- Biotech
- Где находится
- United States
Подтверждённая выручка: пока не подключена
HarborSite — ваш стартап? Запросите эту страницу и подключите Stripe, App Store или Google Play: ваш MRR и рост появятся здесь прямо из источника.
О стартапе
HarborSite is a Harvard/Wyss Institute spinoff developing engineered recombinase enzymes to insert full-length therapeutic genes into safe sites in the genome, aiming at one-time treatments for genetic and age-related diseases. It is at research stage, with an initial focus on liver and blood cells. It is based in Boston, US, and is backed by Armenia-based SmartGate VC.
Команда
- Erik Aznauryan, Co-founder and CEO (Основатель)
- George Church, Co-founder and Scientific Advisory Board Chair (Основатель)
- Tina Lebar, Co-founder and Scientific Advisory Board Member (Основатель)
Аудитория
Подписчики в соцсетях
Данные профиля: Stanbase.